Pictured (from l-r): Frank Ryan, Chairperson, IDA Ireland, Albert Bourla, Pfizer Global Chairman & CEO, Taoiseach Leo Varadkar and Michael Lohan, CEO IDA Ireland.
IDA Ireland presented a Special Recognition Award to Pfizer in recognition of their continued commitment to Ireland.
Last week, IDA Ireland presented a Special Recognition Award to Albert Bourla, Pfizer Global Chairman & CEO. The Award was given in recognition for the company’s continued commitment to Ireland, demonstrating the importance and longevity of FDI investments from the Life Sciences sector in delivering economic and social benefit to the country.
Speaking at the event Albert Bourla, Pfizer Global Chairman & CEO, said: “I am really pleased to receive this award from Taoiseach Leo Varadkar and IDA Ireland and want to acknowledge the work of our purpose-driven colleagues here in Ireland. Next year marks our 55th year in Ireland and our commitment to the country remains steadfast.”
Michael Lohan, CEO IDA Ireland: “Pfizer’s enduring commitment to Ireland is testament to the value we offer companies seeking to increase competitiveness through access to state-of-the-art manufacturing facilities, world-class talent, research and innovation.”
Taoiseach Leo Varadkar: “We are determined to stay competitive and protect the large Life Sciences sector located in Ireland, and attract even more investment and quality jobs.”
Pfizer employs over 5,000 people across counties Dublin, Kildare and Cork in manufacturing, shared services, R&D, treasury and commercial operations. Last year, Pfizer announced plans to invest more than €1.2bn to build a new facility that will double the biological drug substance manufacturing capacity at its Grange Castle campus in Dublin.